J&J Innovative Medicine EMEA

Johnson & Johnson Innovative Medicine is dedicated to transforming the future of healthcare by tackling critical public health challenges across Europe, the Middle East, and Africa. Inspired by the legacy of Dr. Paul Janssen, the brand focuses on science-based innovations in diverse areas such as Oncology, Immunology, Neuroscience, Pulmonary Hypertension, Communicable Diseases, and Cardiopulmonary care. By combining rigorous scientific methods with a compassionate approach, Johnson & Johnson aims to address some of the most complex diseases of our time.

The company also prioritizes patient empowerment, ensuring that high-quality treatments are accompanied by accessible information. Additionally, they invest in educational programs for healthcare professionals, emphasizing collaboration and ethical standards in all business areas. Through initiatives like JLABS and established Innovation Centers, Johnson & Johnson fosters a network of creativity and advancement in the healthcare sector. Committed to sustainable access models and innovative solutions, Johnson & Johnson Innovative Medicine is at the forefront of making disease a thing of the past while enhancing the quality of life for patients.